Advertisement

Topics

Korlyns Pharmaceuticals International UK Company Profile

04:20 EDT 19th June 2018 | BioPortfolio

The company started from a humble beginning as CIJEY NIG. LTD IN 1984. Then it operated as a general trading Company in the importation of general goods, and cosmetics from China and the U.K. Cijey were also agents to several local manufacturing Industries.In 1996 Cijey diversified into the Pharmaceutical Industry, initially as distributors to several local manufacturing outfits, Pharmaceutical importers and Pharmaceutical Multinational Corporations. This was taken a step further with the importation of Pharmaceutical products from the United Kingdom. With the increased sales and the uniqueness of the Pharmaceutical market, it was decided to separate the pharmaceutical business of Cijey, and Korlyns Pharmaceuticals was created in January 2000, and was fully incorporated as a Limited Liability company in February 2002.

Location

404 Katherine Road
London
London
E7 8NP
United Kingdom

Contact

Phone: 44- 020 8472 0461
Fax: 44- 020 8471 3335
Email: enquiries@korlynspharm.com


News Articles [687 Associated News Articles listed on BioPortfolio]

Cannabics Pharmaceuticals Files an International Patent Application on Methods for Testing and Predicting Therapeutic Effectiveness of Cannabinoids for Cancer Patients

TEL-AVIV, Israel, January 2, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has filed an international patent application with the PCT authorities on meth...

Investor Network: Valeant Pharmaceuticals International Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Valeant Pharmaceuticals International Inc (NYSE: VRX) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, ...

Deals this week: Melinta Therapeutics, Cipher Pharmaceuticals, Baxter International

Melinta Therapeutics plans to raise $114.88m by issuing 6,920,714 shares of its common stock, priced at $16.6 a share. The US-based...Read More... The post Deals this week: Melinta Therapeutics, Ciph...

Valeant Pharmaceuticals agrees to divest $2.1bn in assets

Valeant Pharmaceuticals International has agreed to sell about $2.1bn in assets as it seeks to reduce over $30bn in debt.

Valeant Pharmaceuticals International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19022018] Prices from USD $350

Valeant Pharmaceuticals International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Valeant Pharmaceuticals International, Inc. Mergers Acquisition...

Valeant to divest iNova Pharmaceuticals for $930m

Valeant Pharmaceuticals International has agreed to divest its iNova Pharmaceuticals business for around $930m.

Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

DUBLIN, June 11, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC (collectively, "Endo" ...

Valeant Suffers Psoriasis Setback

Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-base...

PubMed Articles [666 Associated PubMed Articles listed on BioPortfolio]

Third International Electronic Conference on Medicinal Chemistry (ECMC-3).

The third International Electronic Conference on Medicinal Chemistry, organized and sponsored by MDPI AG, publisher, and the journal Pharmaceuticals, took place in November 2017 on the SciForum websit...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [1160 Associated Clinical Trials listed on BioPortfolio]

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Pr...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [2606 Associated Companies listed on BioPortfolio]

Korlyns Pharmaceuticals International UK

The company started from a humble beginning as CIJEY NIG. LTD IN 1984. Then it operated as a general trading Company in the importation of general goods, and cosmetics from China and the U.K. Cijey we...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Alantos Pharmaceuticals Holding, Inc.

Alantos Pharmaceuticals is a dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals for Arthritic and Metabolic diseases. Headquartered in Cambridge, MA, ...

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prost...

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The...

More Information about "Korlyns Pharmaceuticals International UK" on BioPortfolio

We have published hundreds of Korlyns Pharmaceuticals International UK news stories on BioPortfolio along with dozens of Korlyns Pharmaceuticals International UK Clinical Trials and PubMed Articles about Korlyns Pharmaceuticals International UK for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Korlyns Pharmaceuticals International UK Companies in our database. You can also find out about relevant Korlyns Pharmaceuticals International UK Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record